Holen Sie sich die Stockscreener-App
1.71
4.27%
0.07
Schlusskurs vom Vortag:
$1.64
Offen:
$1.62
24-Stunden-Volumen:
93,571
Relative Volume:
0.31
Marktkapitalisierung:
$53.34M
Einnahmen:
$1.05M
Nettoeinkommen (Verlust:
$-48.82M
KGV:
-0.9344
EPS:
-1.83
Netto-Cashflow:
$-47.49M
1W Leistung:
+3.64%
1M Leistung:
+1.18%
6M Leistung:
+46.15%
1J Leistung:
-19.34%
1-Tages-Spanne:
$1.62
$1.74
1-Wochen-Bereich:
$1.60
$1.76
52-Wochen-Spanne:
$1.06
$2.41
Actinium Pharmaceuticals Inc Stock (ATNM) Company Profile
Firmenname
Actinium Pharmaceuticals Inc
Sektor
Branche
Telefon
646-767-3870
Adresse
275 Madison Avenue, 7th Floor, New York, NY
Vergleichen Sie ATNM mit anderen Aktien
| Aktien | Preis | Marktkapitalisierung | Umsatz | Nettogewinn | Free Cashflow | ENV |
|---|---|---|---|---|---|---|
ATNM
Actinium Pharmaceuticals Inc
|
1.71 | 53.34M | 1.05M | -48.82M | -47.49M | -1.83 |
|
VRTX
Vertex Pharmaceuticals Inc
|
396.76 | 99.96B | 11.39B | 3.64B | 3.50B | 13.99 |
|
REGN
Regeneron Pharmaceuticals Inc
|
599.24 | 60.83B | 14.21B | 4.46B | 3.56B | 39.68 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
464.75 | 59.89B | 2.46B | -319.09M | -52.09M | -2.47 |
|
ARGX
Argen X Se Adr
|
663.51 | 40.47B | 3.06B | 1.28B | 447.35M | 21.30 |
|
ONC
Beone Medicines Ltd Adr
|
314.35 | 37.96B | 3.81B | -644.79M | -669.77M | -6.24 |
Actinium Pharmaceuticals Inc Stock (ATNM) Upgrades & Downgrades
| Datum | Aktion | Analytiker | Ratingänderung |
|---|---|---|---|
| 2024-08-07 | Herabstufung | B. Riley Securities | Buy → Neutral |
| 2024-05-14 | Eingeleitet | Stephens | Overweight |
| 2023-09-06 | Eingeleitet | HSBC Securities | Buy |
| 2023-02-21 | Herabstufung | William Blair | Outperform → Mkt Perform |
| 2022-09-08 | Eingeleitet | Cantor Fitzgerald | Overweight |
| 2022-08-25 | Eingeleitet | B. Riley Securities | Buy |
| 2020-11-05 | Eingeleitet | Alliance Global Partners | Buy |
| 2017-12-06 | Eingeleitet | B. Riley FBR, Inc. | Buy |
| 2017-10-23 | Fortgesetzt | ROTH Capital | Buy |
| 2017-09-14 | Eingeleitet | Maxim Group | Buy |
| 2016-08-25 | Eingeleitet | ROTH Capital | Buy |
| 2016-02-29 | Eingeleitet | H.C. Wainwright | Buy |
| 2015-10-15 | Eingeleitet | FBR Capital | Outperform |
| 2014-10-01 | Eingeleitet | MLV & Co | Buy |
| 2014-07-22 | Eingeleitet | Canaccord Genuity | Buy |
Alle ansehen
Actinium Pharmaceuticals Inc Aktie (ATNM) Neueste Nachrichten
Will Actinium Pharmaceuticals Inc. see short term momentumPortfolio Performance Summary & Smart Money Movement Tracker - Newser
What to expect from Actinium Pharmaceuticals Inc. in the next 30 daysMarket Activity Recap & Entry Point Confirmation Signals - Newser
Can Actinium Pharmaceuticals Inc. hit a new high this monthJuly 2025 Spike Watch & High Return Trade Opportunity Guides - Newser
Reversal Traders Monitor Actinium Pharmaceuticals Inc. for EntryMarket Risk Analysis & Risk Controlled Daily Trade Plans - mustnews.co.kr
Will Actinium Pharmaceuticals Inc. rebound enough to break evenJuly 2025 Macro Moves & High Conviction Buy Zone Alerts - Newser
Will Actinium Pharmaceuticals Inc. price bounce be sustainableQuarterly Profit Review & Fast Exit and Entry Strategy Plans - Newser
How to manage a losing position in Actinium Pharmaceuticals Inc.Earnings Summary Report & Long-Term Growth Plans - Newser
How to track smart money flows in Actinium Pharmaceuticals Inc.2025 Trading Recap & Fast Gaining Stock Strategy Reports - Newser
What indicators show strength in Actinium Pharmaceuticals Inc.2025 Market Trends & AI Forecasted Entry and Exit Points - Newser
Does Actinium Pharmaceuticals Inc. qualify in momentum factor screeningRecession Risk & Low Risk Entry Point Tips - Newser
Sector ETF performance correlation with Actinium Pharmaceuticals Inc.2025 Investor Takeaways & Long-Term Safe Investment Plans - Newser
Predicting Actinium Pharmaceuticals Inc. trend using moving averagesJobs Report & Weekly Breakout Opportunity Watchlist - Newser
Will Volume Confirm Reversal in Actinium Pharmaceuticals Inc.July 2025 Summary & Technical Confirmation Alerts - newsyoung.net
Analyzing drawdowns of Actinium Pharmaceuticals Inc. with statistical toolsJuly 2025 PreEarnings & Consistent Profit Trading Strategies - Newser
Actinium Pharmaceuticals Inc.’s volatility index tracking explainedQuarterly Market Review & Verified Entry Point Signals - Newser
Visual analytics tools that track Actinium Pharmaceuticals Inc. performance2025 Sector Review & High Yield Stock Recommendations - Newser
Visualizing Actinium Pharmaceuticals Inc. stock with heatmaps2025 Top Gainers & Technical Pattern Alert System - Newser
Is Actinium Pharmaceuticals Inc. meeting your algorithmic filter criteria2025 Trading Recap & Weekly Watchlist for Hot Stocks - Newser
Can machine learning forecast Actinium Pharmaceuticals Inc. recoveryMarket Risk Analysis & High Accuracy Buy Signal Tips - Newser
What’s next for Actinium Pharmaceuticals Inc. stock priceTrade Entry Summary & Detailed Earnings Play Strategies - Newser
Actinium Pharmaceuticals Inc. recovery potential after sell offExit Point & Weekly Momentum Picks - Newser
Does Actinium Pharmaceuticals Inc. stock reflect fundamentalsWeekly Gains Report & AI Powered Market Entry Ideas - thegnnews.com
What institutional flow reveals about Actinium Pharmaceuticals Inc.Sell Signal & Precise Swing Trade Entry Alerts - Newser
Is Actinium Pharmaceuticals Inc. showing signs of accumulation2025 Market WrapUp & Verified Momentum Stock Watchlist - Newser
Has Actinium Pharmaceuticals Inc. formed a bullish divergenceJuly 2025 Review & Weekly Breakout Watchlists - Newser
Is Actinium Pharmaceuticals Inc. a Top Dividend Stock to Watch in 2025Earnings Recap Report & Fast Moving Stock Watchlists - Newser
Actinium Pharmaceuticals Inc. Price Targets Raised After ReboundWeekly Investment Recap & Community Consensus Trade Signals - beatles.ru
What moving averages say about Actinium Pharmaceuticals IncFree Swing Trade With Risk Management - Newser
Finanzdaten der Actinium Pharmaceuticals Inc-Aktie (ATNM)
Umsatz
Nettogewinn
Free Cashflow
ENV
1.33%
0.64%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):